PIPERACILLIN AND TAZOBACTAM FOR INJECTION
FRESENIUS KABI CANADA LTD
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is PIPERACILLIN AND TAZOBACTAM FOR INJECTION discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that PIPERACILLIN AND TAZOBACTAM FOR INJECTION 4.5G 36G has been permanently discontinued (last updated August 20, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is PIPERACILLIN AND TAZOBACTAM FOR INJECTION not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02465833
Strength
4.5G 36G
Dosage Form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Active Ingredient
TAZOBACTAM PIPERACILLIN
Compare with another product →
Shortage History
Other Products from FRESENIUS KABI CANADA LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
900MG · DIN 02395150
20MG · DIN 02538644
50MG · DIN 02403536
50MG · DIN 02236926
DIN 02497697
3MG · DIN 02457482
3MG · DIN 02267659
3MG · DIN 02457474
50MG · DIN 02245248
250MG · DIN 02227029
2G · DIN 02226995
1G · DIN 02227002